MétaCan
Menu
Back to cohort
Record W4386594957 · doi:10.1016/s2213-8587(23)00223-1

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

2023· article· en· W4386594957 on OpenAlexfundno aff
Stephen Kaptoge, SRK Seshasai, Liang Sun, Mark Walker, Tom Bolton, Sue Spackman, Feven Ataklte, Peter Willeit, Steven Bell, Stephen Burgess, Lisa Pennells, Servet Altay, Gerd Assmann, Yoav Ben‐Shlomo, LG Best, Cecilia Björkelund, D.T. Blazer, Hermann Brenner, Eric J. Brunner, Dagenais Gr, John A. Cooper, Cyrus Cooper, CJ Crespo, Mary Cushman, RB D’Agostino, Makoto Daimon, Lori B. Daniels, Rosie Danker, Karina W. Davidson, RT de Jongh, Chiara Donfrancesco, Pierre Ducimetière, PJM Elders, Gunnar Engström, Ian Ford, I Gallacher, SJL Bakker, Uri Goldbourt, G de La Cámara, Sameline Grimsgaard, Vilmundur Guðnason, PO Hansson, Hironori Imano, J. Wouter Jukema, Christopher Kabrhel, Jussi Kauhanen, Maryam Kavousi, Stefan Kiechl, Matthew Knuiman, Daan Kromhout, HM Krumholz, Kuller Lh, Tiina Laatikainen, DA Lowler, HE Meyer, Kenneth J. Mukamal, Paul J. Nietert, Toshiharu Ninomiya, Dorothea Nitsch, Børge G. Nordestgaard, Luigi Palmieri, Jackie F. Price, P. M. Ridker, Qi Sun, Annika Rosengren, Ronan Roussel, Masaru Sakurai, Veikko Salomaa, Ben Schöttker, JE Shaw, Timo Strandberg, Johan Sundström, Hanna Tolonen, Aage Tverdal, WMM Verschuren, Henry Völzke, Lynne E. Wagenknecht, RB Wallace, S. Goya Wannamethee, N J Wareham, Sylvia Wassertheil‐Smoller, Kazumasa Yamagishi, Bu B. Yeap, Seamus C. Harrison, Michael Inouye, Simon J. Griffin, AS Butterworth, Angela Wood, SG Thompson, Naveed Sattar, John Danesh, Emanuele Di Angelantonio, RW Tipping, Sarah Russell, Michelle C. Johansen, MP Bancks, Morgana Mongraw‐Chaffin, Dianna J. Magliano, ELM Barr, PZ Zimmet, Peter H. Whincup, Johann Willeit, Christoph Leitner, Debbie A. Lawlor, P C Elwood, Susan E. Sutherland, Kelly J. Hunt, RM Selmer, LL Haheim, Inger Ariansen, A Tybjaer-Hansen, R Frikkle-Schmidt, Anne Langsted, Cinzia Lo Noce, Beverley Balkau, Fabrice Bonnet, Frédéric Fumeron, DL Pablos, CR Ferro, T Julieth Parra Morales, Stela McLachlan, Jack M. Guralnik, K-T Khaw, Bernd Holleczek, Hannah Stocker, Aulikki Nissinen, Erkki Vartiainen, Pekka Jousilahti, Kennet Harald, JM Massaro, Michael Pencina, Asya Lyass, Shinji Susa, Toshihide Oizumi, Takamasa Kayama, Angela Chetrit, Jesse Roth, Liat Orenstein, Lennart Welin, Kurt Svärdsudd, Lauren Lissner, Dominique Hange, Kirsten Mehlig, R. S. Tilvis, Elaine Dennison, Leo D. Westbury, PE Norman, Osvaldo P. Almeida, Graeme J. Hankey, Jun Hata, Mamoru Shibata, Yoshihiko Furuta, MT Bom, Femke Rutters, Mirthe Muilwijk, Peter Kraft, Sara Lindström, Constance Turman, Masahiko Kiyama, Akihiko Kitamura, Yariv Gerber, J T Salonen, LN van Schoor, EM van Zutphen, Olle Melander, BM Psaty, Michael J. Blaha, IH de Boer, RA Kronmal, G Grandits, HC Shin, JR Albertorio, RF Gillum, FB Hu, Steve E. Humphries, F Hill- Briggs, Elizabeth A. Vrany, Melissa G. Butler, JE Schwartz, Hiroyasu Iso, Philippe Amouyel, Dominique Arveiler, Jean Ferrières, RT Gansevoort, Rudolf A. de Boer, Lyanne M. Kieneker, Stella Trompet, Patricia M. Kearney, Bernard Cantin, JP Després, Benoı̂t Lamarche, Gail A. Laughlin, Linda K. McEvoy, Thor Aspelund, Gunnar Sigurðsson, Martijn J. Tilly, MA Ikram, Marcus Dörr, Sabine Schipf, AM Fretts, JG Umans, Tauqeer Ali, Nawar Shara, Günay Can, H. Gülru Yüksel, Uğur Özkan, H. Nakagawa, Yuko Morikawa, Masao Ishizaki, Inger Njølstad, Tom Wilsgaard, Ellisiv B. Mathiesen, Julie E. Buring, Nancy R. Cook, Volker Arndt, Dietrich Rothenbacher, JoAnn E. Manson, Lesley F. Tinker, M Shipley, Ádám G. Tabák, Mika Kivimäki, Chris J. Packard, Michele Robertson, Edith J. M. Feskens, Johanna M. Geleijnse

Bibliographic record

VenueThe Lancet Diabetes & Endocrinology · 2023
Typearticle
Languageen
FieldMedicine
TopicDiabetes, Cardiovascular Risks, and Lipoproteins
Canadian institutionsnot available
FundersNorwegian Institute of Public HealthFaculty of Medicine and Health, University of SydneyEconomic and Social Research CouncilInstitut universitaire de cardiologie et de pneumologie de Québec, Université LavalBiogenAgency for Healthcare Research and QualityNational Institutes of HealthNational Health and Medical Research CouncilDementias Platform UKAstraZenecaBaker Heart and Diabetes InstituteHjartaverndWellcome TrustUniversität InnsbruckTerveyden ja hyvinvoinnin laitosMedizinische Universität InnsbruckLunds UniversitetFaculty of Health and Medical Sciences, University of Western AustraliaOulun YliopistoHirosaki UniversityGöteborgs UniversitetSahlgrenska UniversitetssjukhusetNetherlands Heart InstituteUniversitair Medisch Centrum GroningenÖsterreichische ForschungsförderungsgesellschaftNovo NordiskGentofte HospitalRijksinstituut voor Volksgezondheid en MilieuMassachusetts Medical SocietyYonsei UniversityDet Sundhedsvidenskabelige Fakultet, Københavns UniversitetUniversiteit UtrechtRijksuniversiteit GroningenSt. George's, University of LondonInstitut National de la Santé et de la Recherche MédicaleFondation LeducqIstituto Superiore di SanitàSchool of Medicine, Duke UniversityUniversity of OxfordMedical Research CouncilGrifolsServierUppsala UniversitetAmarin CorporationTel Aviv UniversityNovo Nordisk UK Research FoundationLondon School of Hygiene and Tropical MedicineWake Forest School of MedicineDepartment of Health and Social CareAmsterdam University Medical CentersNorthwell HealthEsperion TherapeuticsHealth Services Research and DevelopmentUniversity of TorontoKowa CompanyHarvard UniversityDeutsches KrebsforschungszentrumQueen Mary University of LondonVanderbilt University Medical CenterNational Institute for Health and Care ResearchCenters for Disease Control and PreventionSanofiLeids Universitair Medisch CentrumUniversity of VermontNIHR Cambridge Biomedical Research CentreMassachusetts General HospitalUniversity College LondonDiabetes UKUniversity of SouthamptonNational Heart, Lung, and Blood InstituteUniversiteit LeidenUniversity of GlasgowAbbott LaboratoriesUniversity of South CarolinaFiona Stanley HospitalHáskóli ÍslandsBritish Heart FoundationUniversity of PittsburghPortland State UniversityUniversitetet i TromsøSchool of Medicine, Boston UniversityHelsingin YliopistoPfizerYale UniversityUniversity of BristolTrakya ÜniversitesiState of Connecticut Department of Public HealthVästra GötalandsregionenEli Lilly and CompanyUniversity of TsukubaItä-Suomen YliopistoBrigham and Women's HospitalUniversity of California, San DiegoAmgenKanazawa Medical UniversityMylanRegeneron PharmaceuticalsAmerican Heart AssociationUniversität HeidelbergSahlgrenska AkademinWake Forest University
KeywordsMedicineLife expectancyGerontologyDemographyDiabetes mellitusType 2 diabetesEnvironmental healthPopulation

Abstract

fetched live from OpenAlex

BACKGROUND: The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. We aimed to provide reliable estimates of the associations between age at diagnosis of diabetes and all-cause mortality, cause-specific mortality, and reductions in life expectancy. METHODS: For this observational study, we conducted a combined analysis of individual-participant data from 19 high-income countries using two large-scale data sources: the Emerging Risk Factors Collaboration (96 cohorts, median baseline years 1961-2007, median latest follow-up years 1980-2013) and the UK Biobank (median baseline year 2006, median latest follow-up year 2020). We calculated age-adjusted and sex-adjusted hazard ratios (HRs) for all-cause mortality according to age at diagnosis of diabetes using data from 1 515 718 participants, in whom deaths were recorded during 23·1 million person-years of follow-up. We estimated cumulative survival by applying age-specific HRs to age-specific death rates from 2015 for the USA and the EU. FINDINGS: For participants with diabetes, we observed a linear dose-response association between earlier age at diagnosis and higher risk of all-cause mortality compared with participants without diabetes. HRs were 2·69 (95% CI 2·43-2·97) when diagnosed at 30-39 years, 2·26 (2·08-2·45) at 40-49 years, 1·84 (1·72-1·97) at 50-59 years, 1·57 (1·47-1·67) at 60-69 years, and 1·39 (1·29-1·51) at 70 years and older. HRs per decade of earlier diagnosis were similar for men and women. Using death rates from the USA, a 50-year-old individual with diabetes died on average 14 years earlier when diagnosed aged 30 years, 10 years earlier when diagnosed aged 40 years, or 6 years earlier when diagnosed aged 50 years than an individual without diabetes. Using EU death rates, the corresponding estimates were 13, 9, or 5 years earlier. INTERPRETATION: Every decade of earlier diagnosis of diabetes was associated with about 3-4 years of lower life expectancy, highlighting the need to develop and implement interventions that prevent or delay the onset of diabetes and to intensify the treatment of risk factors among young adults diagnosed with diabetes. FUNDING: British Heart Foundation, Medical Research Council, National Institute for Health and Care Research, and Health Data Research UK.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.791

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.249
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations211
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Diabetes & EndocrinologySame topicDiabetes, Cardiovascular Risks, and LipoproteinsFrench-language works237,207